Cargando…
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
Background: In COVID-19 patients, aldosterone via angiotensin-converting enzyme-2 deregulation may be responsible for systemic and pulmonary vasoconstriction, inflammation, and oxidative organ damage. Aim: To verify retrospectively the impact of the mineralcorticoid receptor antagonist canrenone i.v...
Autores principales: | Vicenzi, Marco, Ruscica, Massimiliano, Iodice, Simona, Rota, Irene, Ratti, Angelo, Di Cosola, Roberta, Corsini, Alberto, Bollati, Valentina, Aliberti, Stefano, Blasi, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564548/ https://www.ncbi.nlm.nih.gov/pubmed/32933039 http://dx.doi.org/10.3390/jcm9092943 |
Ejemplares similares
-
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients
por: Vicenzi, Marco, et al.
Publicado: (2020) -
Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience
por: Ruscica, Massimiliano, et al.
Publicado: (2021) -
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study
por: Papotti, Bianca, et al.
Publicado: (2021) -
Simultaneous Identification and Quantification of Canrenone and 11-α-Hydroxy-Canrenone by LC-MS and HPLC-UVD
por: Huang, Da-Ming, et al.
Publicado: (2011) -
The Decrease of Mineralcorticoid Receptor Drives Angiogenic Pathways in Colorectal Cancer
por: Tiberio, Laura, et al.
Publicado: (2013)